$PGNX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PROGENICS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PROGENICS PHARMACEUTICALS INC. Get notifications about new insider transactions in PROGENICS PHARMACEUTICALS INC for free.
Page: < prev 1 ... 9 10 11 12 13
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21 2004 | PGNX | PROGENICS PHARMACE ... | PRENTKI RONALD J | President | Sell | S | 19.65 | 1,500 | 29,475 | 0 | 1.5 K to 0 (-100.00 %) |
| Apr 21 2004 | PGNX | PROGENICS PHARMACE ... | PRENTKI RONALD J | President | Sell | S | 19.60 | 1,000 | 19,600 | 0 | 1,000 to 0 (-100.00 %) |
| Apr 21 2004 | PGNX | PROGENICS PHARMACE ... | PRENTKI RONALD J | President | Sell | S | 19.50 | 1,000 | 19,500 | 0 | 1,000 to 0 (-100.00 %) |
| Apr 21 2004 | PGNX | PROGENICS PHARMACE ... | PRENTKI RONALD J | President | Buy | M | 9.25 | 5,000 | 46,250 | 0 | -5,000 to 0 (-100.00 %) |
| Apr 21 2004 | PGNX | PROGENICS PHARMACE ... | PRENTKI RONALD J | President | Sell | S | 19.90 | 1,000 | 19,900 | 0 | 1,000 to 0 (-100.00 %) |
| Apr 21 2004 | PGNX | PROGENICS PHARMACE ... | PRENTKI RONALD J | President | Sell | S | 20.00 | 2,000 | 40,000 | 0 | 2 K to 0 (-100.00 %) |
| Apr 21 2004 | PGNX | PROGENICS PHARMACE ... | PRENTKI RONALD J | President | Buy | M | 9.25 | 3,000 | 27,750 | 0 | -3,000 to 0 (-100.00 %) |
| Apr 21 2004 | PGNX | PROGENICS PHARMACE ... | PRENTKI RONALD J | President | Sell | S | 19.85 | 1,000 | 19,850 | 0 | 1,000 to 0 (-100.00 %) |
| Apr 21 2004 | PGNX | PROGENICS PHARMACE ... | PRENTKI RONALD J | President | Sell | S | 19.80 | 2,000 | 39,600 | 0 | 2 K to 0 (-100.00 %) |
| Apr 21 2004 | PGNX | PROGENICS PHARMACE ... | PRENTKI RONALD J | President | Buy | M | 9.25 | 3,000 | 27,750 | 0 | -3,000 to 0 (-100.00 %) |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | PRENTKI RONALD J | President | Grant | A | 11.51 | 142 | 1,634 | 16,634 | 16.5 K to 16.6 K (+0.86 %) |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | Vice President, Fin ... | Option Exercise | A | 15.06 | 8,000 | 120,480 | 8,000 | |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | Vice President, Fin ... | Option Exercise | A | 12.29 | 8,000 | 98,320 | 8,000 | |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | Vice President, Fin ... | Option Exercise | A | 17.19 | 6,000 | 103,140 | 6,000 | |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | Vice President, Fin ... | Option Exercise | A | 13.63 | 6,000 | 81,750 | 6,000 | |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | Vice President, Fin ... | Option Exercise | A | 9.25 | 4,800 | 44,400 | 4,800 | |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | Vice President, Fin ... | Option Exercise | A | 10.00 | 1,733 | 17,330 | 1,733 | |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | Vice President, Fin ... | Grant | A | 6.35 | 83 | 527 | 6,167 | 6.1 K to 6.2 K (+1.36 %) |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | SCHEINBERG DAVID A | Director | Option Exercise | A | 10.03 | 1,250 | 12,534 | 1,250 | |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | SCHEINBERG DAVID A | Director | Option Exercise | A | 10.03 | 1,250 | 12,534 | 1,250 | |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Option Exercise | M | 4.00 | 4,500 | 18,000 | 13,250 | |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Option Exercise | M | 4.00 | 2,000 | 8,000 | 0 | |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Grant | A | 10.05 | 118 | 1,186 | 8,788 | 8.7 K to 8.8 K (+1.36 %) |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Sell | S | 18.65 | 2,500 | 46,615 | 0 | 2.5 K to 0 (-100.00 %) |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Buy | M | 4.00 | 2,500 | 10,000 | 0 | -2,500 to 0 (-100.00 %) |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Sell | S | 18.65 | 2,000 | 37,300 | 0 | 2 K to 0 (-100.00 %) |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Buy | M | 4.00 | 2,000 | 8,000 | 0 | -2,000 to 0 (-100.00 %) |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Sell | S | 18.60 | 2,000 | 37,200 | 0 | 2 K to 0 (-100.00 %) |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Buy | M | 4.00 | 2,000 | 8,000 | 0 | -2,000 to 0 (-100.00 %) |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chairman of the Boa ... | Grant | A | 18.71 | 174 | 3,256 | 579,581 | 579.4 K to 579.6 K (+0.03 %) |
| Apr 05 2004 | PGNX | PROGENICS PHARMACE ... | YACHMETZ PHILIP K | VP, General Counsel ... | Grant | A | 8.30 | 98 | 813 | 7,732 | 7.6 K to 7.7 K (+1.28 %) |
| Mar 03 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Option Exercise | M | 4.00 | 4,000 | 16,000 | 19,750 | |
| Mar 03 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Option Exercise | M | 4.00 | 2,500 | 10,000 | 0 | |
| Mar 03 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Sell | S | 21.56 | 1,500 | 32,340 | 8,670 | 10.2 K to 8.7 K (-14.75 %) |
| Mar 03 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Buy | M | 4.00 | 1,500 | 6,000 | 0 | -1,500 to 0 (-100.00 %) |
| Mar 03 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Sell | S | 21.68 | 1,500 | 32,520 | 0 | 1.5 K to 0 (-100.00 %) |
| Mar 03 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Buy | M | 4.00 | 1,500 | 6,000 | 0 | -1,500 to 0 (-100.00 %) |
| Mar 03 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Sell | S | 21.86 | 1,000 | 21,860 | 0 | 1,000 to 0 (-100.00 %) |
| Mar 03 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Buy | M | 4.00 | 1,000 | 4,000 | 0 | -1,000 to 0 (-100.00 %) |
| Mar 03 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Sell | S | 22.20 | 2,000 | 44,400 | 0 | 2 K to 0 (-100.00 %) |
| Mar 03 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Buy | M | 4.00 | 2,000 | 8,000 | 0 | -2,000 to 0 (-100.00 %) |
| Mar 03 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Sell | S | 22.60 | 500 | 11,300 | 0 | 500 to 0 (-100.00 %) |
| Mar 03 2004 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior Vice Preside ... | Buy | M | 4.00 | 500 | 2,000 | 0 | -500 to 0 (-100.00 %) |
| Feb 20 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | V.P., Finance & Adm ... | Option Exercise | M | 4.00 | 1,500 | 6,000 | 0 | |
| Feb 20 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | V.P., Finance & Adm ... | Option Exercise | M | 4.00 | 2,000 | 8,000 | 0 | |
| Feb 20 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | V.P., Finance & Adm ... | Option Exercise | M | 4.00 | 4,000 | 16,000 | 0 | |
| Feb 20 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | V.P., Finance & Adm ... | Sell | S | 21.50 | 1,500 | 32,250 | 6,084 | 7.6 K to 6.1 K (-19.78 %) |
| Feb 20 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | V.P., Finance & Adm ... | Buy | M | 4.00 | 1,500 | 6,000 | 0 | -1,500 to 0 (-100.00 %) |
| Feb 20 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | V.P., Finance & Adm ... | Sell | S | 21.51 | 2,000 | 43,010 | 0 | 2 K to 0 (-100.00 %) |
| Feb 20 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | V.P., Finance & Adm ... | Buy | M | 4.00 | 2,000 | 8,000 | 0 | -2,000 to 0 (-100.00 %) |
| Feb 20 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | V.P., Finance & Adm ... | Sell | S | 21.50 | 4,000 | 86,000 | 0 | 4 K to 0 (-100.00 %) |
| Feb 20 2004 | PGNX | PROGENICS PHARMACE ... | MCKINNEY ROBERT A | V.P., Finance & Adm ... | Buy | M | 4.00 | 4,000 | 16,000 | 0 | -4,000 to 0 (-100.00 %) |